Issue
The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Losartan sensitizes selectively prostate cancer cell to ionizing radiation
Corresponding Author(s) : H Yazdannejat
Cellular and Molecular Biology,
Vol. 62 No. 1: Issue 1
Abstract
Losartan is an angiotensin II receptor (AT-II-R) blocker that is widely used by human for blood pressure regulation. Also, it has antitumor property. In this study, we investigated the radiosensitizing effect of losartan on cellular toxicity induced by ionizing radiation on prostate cancer and non-malignant fibroblast cells. Human prostate cancer (DU-145) and human non-malignant fibroblast cells (HFFF2) were treated with losartan at different concentrations (0.5, 1, 10, 50 and 100 µM) and then these cells were exposed to ionizing radiation. The cell proliferation was determined using MTT assay. Our results showed that losartan exhibited antitumor effect on prostate cancer cells; it was reduced cell survival to 66% at concentration 1 µM. Losartan showed an additive killing effect in combination with ionizing radiation on prostate cancer cell. The cell proliferation was reduced to 54% in the prostate cancer cells treated with losartan at concentration 1 µM in combination with ionizing radiation. Losartan did not exhibit any toxicity on HFFF2 cell. This result shows a promising effect of losartan on enhancement of therapeutic effect of ionizing radiation in patients during therapy.
Keywords
Losartan
angiotensin II receptor
anti-proliferation
ionizing radiation
prostate cancer
radiosensitive effect.
Yazdannejat, H., Hosseinimehr, S. J., Ghasemi, A., Pourfallah, T. A., & Rafiei, A. (2016). Losartan sensitizes selectively prostate cancer cell to ionizing radiation. Cellular and Molecular Biology, 62(1), 30–33. Retrieved from https://mail.cellmolbiol.org/index.php/CMB/article/view/776
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX